The relationship between angiotensin-converting enzyme gene polymorphism and heart rate variability in cerebral stroke

Chinese Journal of Medical Genetics

Volumn 21, Issue 2, 2004, Pages 156-160

  Wang, Yi Ming ^a   Liu, Xing De ^b   Dong, Wei Wei ^c   Yang, Zong Cheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Cerebral stroke; Gene polymorphism; Heart rate variability

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE VARIABILITY; HEREDITY; HUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR;

AGED; CEREBROVASCULAR ACCIDENT; FEMALE; GENOTYPE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

INSERTION SEQUENCES;

EID: 1942439983     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Busjahn A, Voss A, Knoblauch H, et al. Angiotensin converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins. Am J Cardiol, 1998, 81: 755-760.
2. Luft FC. Bad genes, good people, association, linkage longevity and the prevention of cardiovascular disease. Clin Exp Pharmacol Physiol, 1999, 26: 576-579.
3. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J, 1996, 17: 354-381.
4. Kamath MV, Fallen EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng, 1993, 21: 245-311.
5. Chen YZ, Lei H, Xie Y, et al. Assay for quantitative detection of heart autonomic nerve activity, Chin J Cardiol, 1992, 20: 101-103.
6. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin conversion enzyme gene(DCP1) (dipeptidyl caroxypeptidase 1). Nuceil Acids Res, 1992, 20: 1433.
7. Sharma P, Carter ND, Barley J, et al. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens, 1994, 8: 645-648.
8. Catto A, Carter AM, Barrett JH, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke, 1996, 27: 435-440.
9. Xu YB, Wang XJ, Zhu JS, et al. Angiotensin converting enzyme gene polymorphism and cerebrovascular disease. Chin J Neurol, 1998, 31: 152-155.
10. Markus HS, Barley J, Lunt R, et al, Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke, 1995, 26: 1329-1333.
11. Rigat B, Hubert C, Alhenc-Gelas F, et al, An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 1990, 86: 1343-1346.
12. Binkley PF, Nunziata E, Haas GJ, et al. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure. Am Heart J, 2000, 140: 34-42.
13. Kontopoulos AG, Athyros VG, Papageorgion AA, et al. Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction. Am J Cardiol, 1999, 84: 1164-1169.